- Home
- CRBU vs MPV Comparison
CRBU vs MPV Comparison
Compare CRBU & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- MPV
- Stock Information
- Founded
- CRBU 2011
- MPV 1988
- Country
- CRBU United States
- MPV United States
- Employees
- CRBU N/A
- MPV N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- MPV Finance Companies
- Sector
- CRBU Health Care
- MPV Finance
- Exchange
- CRBU Nasdaq
- MPV Nasdaq
- Market Cap
- CRBU 151.2M
- MPV 181.3M
- IPO Year
- CRBU 2021
- MPV N/A
- Fundamental
- Price
- CRBU $1.31
- MPV $16.90
- Analyst Decision
- CRBU Strong Buy
- MPV
- Analyst Count
- CRBU 5
- MPV 0
- Target Price
- CRBU $11.80
- MPV N/A
- AVG Volume (30 Days)
- CRBU 1.3M
- MPV 25.2K
- Earning Date
- CRBU 03-10-2025
- MPV 01-01-0001
- Dividend Yield
- CRBU N/A
- MPV 8.71%
- EPS Growth
- CRBU N/A
- MPV N/A
- EPS
- CRBU N/A
- MPV 1.71
- Revenue
- CRBU $11,475,000.00
- MPV N/A
- Revenue This Year
- CRBU N/A
- MPV N/A
- Revenue Next Year
- CRBU N/A
- MPV N/A
- P/E Ratio
- CRBU N/A
- MPV $9.35
- Revenue Growth
- CRBU N/A
- MPV N/A
- 52 Week Low
- CRBU $1.22
- MPV $11.18
- 52 Week High
- CRBU $8.33
- MPV $16.42
- Technical
- Relative Strength Index (RSI)
- CRBU 39.05
- MPV 48.99
- Support Level
- CRBU $1.30
- MPV $17.03
- Resistance Level
- CRBU $1.46
- MPV $17.77
- Average True Range (ATR)
- CRBU 0.09
- MPV 0.40
- MACD
- CRBU 0.02
- MPV 0.05
- Stochastic Oscillator
- CRBU 33.33
- MPV 50.85
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.